CTL
Showing 26 - 50 of 549
DLBCL (DLBCL) Trial (Tisagenlecleucel)
Withdrawn
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Tisagenlecleucel
- (no location specified)
Feb 25, 2022
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)
Recruiting
- Multiple Sclerosis
- Cellular therapy with EBV specific autologous CTL infusion
-
Nantes, FranceUniversity Hospital
Jan 27, 2021
Neuroblastoma Trial in Houston (EBV specific CTLs)
Active, not recruiting
- Neuroblastoma
- EBV specific CTLs
-
Houston, TexasTexas Children's Hospital
Feb 2, 2022
Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)
Active, not recruiting
- Follicular Lymphoma
- tisagenlecleucel
-
Duarte, California
- +29 more
Nov 2, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)
Active, not recruiting
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- autologous CAR.CD30 EBV specific-CTLs
-
Houston, Texas
- +1 more
Feb 4, 2022
DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- +6 more
- Axicabtagene Ciloleucel
- +10 more
- (no location specified)
Jan 13, 2023
Alcohol Use, Underage, Alcohol Problem Drinking, Substance Use Trial in Los Angeles (Mindfulness Based Relapse Prevention,
Completed
- Alcohol Use, Underage
- +2 more
- Mindfulness Based Relapse Prevention
- Control (CTL)
-
Los Angeles, CaliforniaUniversity of Southern California, School of Social Work
Sep 27, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Abatacept
- +3 more
-
Buffalo, New York
- +2 more
Dec 22, 2022
Cytomegalovirus Infections, Hematological Disease Trial in Shanghai (donor derived cytomegalovirus specific T lymphocytes,
Recruiting
- Cytomegalovirus Infections
- Hematological Disease
- donor derived cytomegalovirus specific T lymphocytes
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated Shanghai General Hospita
Mar 16, 2021
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)
Available
- Epstein-Barr Virus (EBV) Infections
- +11 more
- tabelecleucel
- (no location specified)
Feb 15, 2022
AIDS, BK Virus Infection, Human Immunodeficiency Virus Trial in Houston (Allogeneic BK-specific Cytotoxic T-lymphocytes,
Recruiting
- Acquired Immunodeficiency Syndrome
- +7 more
- Allogeneic BK-specific Cytotoxic T-lymphocytes
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 29, 2021
B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic
Completed
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CTL019 T-cells
-
Los Angeles, California
- +12 more
Oct 29, 2020
HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), HIV-1 Immunogen)
Completed
- HIV Infections
- ALVAC(2)120(B,MN)GNP (vCP1452)
- HIV-1 Immunogen
-
Los Angeles, California
- +8 more
Oct 28, 2021
Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)
Active, not recruiting
- Osteosarcoma
- Neuroblastoma
- GD2 T cells
- +3 more
-
Houston, Texas
- +1 more
Apr 16, 2021
NSCLC, Second-line Treatment Trial in Tianjin (CTL, Toripalimab)
Unknown status
- Non-small Cell Lung Cancer
- Second-line Treatment
- CTL
- Toripalimab
-
Tianjin, Tianjin, China
- +1 more
Jul 5, 2020
Mitochondrial Biogenesis Trial in Kingston (BFR Exercise Training, CTL Exercise Training)
Completed
- Mitochondrial Biogenesis
- BFR Exercise Training
- CTL Exercise Training
-
Kingston, Ontario, CanadaQueen's University
Sep 18, 2020
Therapeutic HIV Vaccination on Control of HIV After
Completed
- HIV Infections
- Therapeutic vaccinations from A5058s
-
Torrance, California
- +13 more
Oct 28, 2021
Gastric Cancer Trial in Jinan (DC vaccine, CTL, Sintilimab Injection)
Recruiting
- Gastric Cancer
- DC vaccine
- +2 more
-
Jinan, Shandong, ChinaThe 2nd Hospital of Shandong University
Sep 25, 2020
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia Trial in
Recruiting
- Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia
- YTB323 and ibrutinib
- YTB323 single agent
-
Tampa, Florida
- +20 more
Feb 24, 2022
Viral Infection, Primary Immune Deficiency Disorder Trial in United States (BK CTL)
Recruiting
- Viral Infection
- Primary Immune Deficiency Disorder
- BK CTL
-
San Francisco, California
- +5 more
Feb 19, 2021
Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)
Recruiting
- Extranodal NK/T-cell Lymphoma
- VT-EBV-N
- Placebo
-
Busan, Korea, Republic of
- +7 more
Apr 28, 2022
Amputation, Transfemoral Amputation, Osseointegration Trial in Aurora (Limb Load Biofeedback Training Intervention, Attention
Recruiting
- Amputation
- +2 more
- Limb Load Biofeedback Training Intervention
- Attention Control
-
Aurora, ColoradoCU Physical Therapy
Jan 31, 2023